Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study

Abstract

The results obtained in real-life conditions confirm that Zarzio(®) is efficient and well tolerated in cancer patients.